Breaking News

IPS Names Process Engineering Director

By Kristin Brooks | January 23, 2014

Schuster brings 25 years of global experience

Tim Schuster has been appointed director of Process Engineering at IPS-Integrated Project Services, Inc. and will be based at the company’s corporate headquarters in Blue Bell, PA.
 
Mr. Schuster has 25 years of global experience in bioprocess engineering, project management and facility and critical utilities systems design, having executed projects in Europe, Asia/Pacific and the U.S. He has expertise with leading technologies within bioprocess and biomanufacturing, including fermentation, single-use systems, process design, large-scale cell culture, recovery, vaccines, isolation and purification. Prior to joining the company, Mr. Schuster held technical leadership positions at Biokinetics, Foster Wheeler and Washington Group International.  
 
“We are pleased to have an expert of Tim’s caliber join IPS,” said Dave Goswami, PE, chief executive officer and chairman, IPS. “Tim brings state-of-the-art knowledge of bioprocess engineering and his experience in complex biotechnology projects in various parts of the world will be a great complement to the strong Biotechnology Team that IPS has developed. The addition of Tim is in line with our focus on becoming the top service provider in the biotechnology sector.”

blog comments powered by Disqus
  • Cryogenic Cold Chain Risk Mitigation

    Cryogenic Cold Chain Risk Mitigation

    Kristin Brooks, Contract Pharma||November 13, 2015
    Mark Sawicki of Cryoport explains the requirements, challenges, and regulatory aspects around cryogenic logistics

  • A Biologic Innovator

    A Biologic Innovator's Pursuit to Uphold Patents

    Kristin Brooks, Contract Pharma||October 12, 2015
    Amgen v. Sandoz biosimilars litigation could impact the industry for years to come

  • 2015 Contracting & Outsourcing Wrap-up

    2015 Contracting & Outsourcing Wrap-up

    Kristin Brooks, Contract Pharma||September 30, 2015
    A huge success, with another year of record attendance, sold-out exhibit hall, and a great line up of informative sessions

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • A Look at DCAT Week ‘16

    Tim Wright, Editor||January 28, 2016
    On the pulse of the pharmaceutical manufacturing value chain, DCAT Week ‘16 will deliver top-flight education programs and networking events.

  • Getting Real

    Michael Pollock, PPD||November 17, 2015
    Partnering for clinical and real-world evidence studies